What is HC Wainwright’s Estimate for SRPT FY2024 Earnings?
Analysts at HC Wainwright raised their FY2024 earnings estimates for Sarepta Therapeutics in a note issued to investors on ...
Assenagon Asset Management S.A. Has $16.11 Million Stake in Sarepta Therapeutics, Inc. (NASDAQ:SRPT)
Assenagon Asset Management S.A. trimmed its stake in Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Free Report) by 62.2% in the ...
Pharmabiz9h
Innovent Biologics, ASK Pharm announce China’s NMPA approval of limertinib to treat metastatic EGFR T790M-mutated NSCLCr
Innovent Biologics, ASK Pharm announce China’s NMPA approval of limertinib to treat metastatic EGFR T790M-mutated NSCLCr: San Francisco Saturday, January 18, 2025, 09:00 Hrs [IS ...
Exxon Mobil and Chevron Megadeals Are Cleared of FTC Antitrust Concerns
Pioneer Natural Resources’ former CEO and Hess’s CEO are prohibited from serving on the oil companies’ boards ...